The autonomy paradox: Predictive genetic testing and autonomy: Three essential problems

Patient Education and Counseling

Volumn 35, Issue 1, 1998, Pages 53-62

  Huibers, Alex K ^a   Van 'T Spijker, Adriaan ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Autonomy; Genetic testing; Threats

Indexed keywords

CLASSIFICATION; ETHICS; GENETIC DISORDER; HUMAN; PREDICTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0032433461     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(98)00083-4     Document Type: Article

References (23)

1. Huggins M., Bloch M., Wiggins S.et al. Predictive testing for Huntington's Disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet. 42:1992;508.
2. Tibben A. What is knowledge but grieving: on psychological effects of DNA-testing for Huntington's disease. PhD Thesis, Erasmus University Rotterdam, 1993.
3. Codori A.M., Brandt J. Psychological costs and benefits of predictive testing for Huntington's Disease. Am J Med Genet (Neuropsychiat Genet). 54:1994;174.
4. Mill J.S. Over vrijheid [On liberty]. Meppel: Boom, 1977.
5. Kant I. Kritik der praktischen Vernunft (Grundlegung zur Metaphysik der Sitten). Frankfurt am Main: Mainz Verlag, 1991.
6. Beauchamp and Childress: Principles of Biomedical Ethics. New York: Oxford University Press, 1989.
7. Van Willigenburg T. Ethiek in praktijk [Ethics in practice]. Assen: Van Gorcum, 1993.
8. Agich G.J. Autonomy and long-term care. New York: Oxford University Press, 1993.
9. Hunfeld J. The grief of late pregnancy loss: a four year follow-up. PhD Thesis, Erasmus University Rotterdam, 1995.
10. Dudok de Wit AC. To know or not to know: the psychological implications of presymptomatic DNA testing for autosomal dominant inheritable late onset disorders. PhD Thesis, Erasmus University Rotterdam, 1997.
11. Kooy L., Tijmstra Tj. Erfelijke ziekten zijn familie-ziekten [Hereditary diseases are family diseases]. Ned Tijdschr Geneeskd. 140:1996;473-475.
12. Wear S. Informed consent. Dordrecht: Kluwer, 1993.
13. Van Zuuren F.J., Wolfs H.M. Styles of coping under threat: personal and situational aspects of monitoring and blunting. Person Indiv Diff. 12:1991;141-149.
14. King M.C., Rowell S., Love S.M. Inherited Breast and Ovarian cancer: what are the risks? what are the choices. J Am Med Assoc. 269:1993;1975-1980.
15. Tijmstra Tj. Het imperatieve karakter van medische technologie en de betekenenis van 'Geanticipeerde Beslissingsspijt' [The imperative character of medical technology and the meaning of 'anticipated regret of decisions']. Ned Tijdschr Geneesk. 131:1987;1128-1132.
16. Bolt I, Goede Raad. Over autonomie en goede redenen in de praktijk van de genetische counseling [Good Advice: on autonomy and good reasons in the practice of genetic counseling], Amsterdam: Thesis Publishers, 1997.
17. Brandt J., Quaid K.A., Folstein S.E.et al. Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's Disease. J Am Med Assoc. 261:1989;3108.
18. Mastromauro C., Myers R.H., Berkman B. Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet. 26:1987;271.
19. Tyler A., Ball D., Craufurd D. Presymptomatic testing for Huntington's disease in the United Kingdom. Br Med J. 304:1992;1593-1596.
20. Dudok de Wit A.C., Tibben A., Frets P.G.et al. BRCA1 in the family: a case description of the psychological implications. Am J Med Genet. 71:1997;63-71.
21. Stratton J.F., Gayther S.A., Russell P.et al. Contribution of BRCA1 mutations to ovarian cancer. New Eng J Med. 336:1997;1125-1130.
22. Ford D., Easton D.F., Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 57:1995;1457-1462.
23. Taylor C. The ethics of authenticity. Cambridge: Harvard University Press, 1991.